Search results for "SCALE"

showing 10 items of 5180 documents

Nonlinear analysis of sleep eeg in depression: Calculation of the largest lyapunov exponent

1995

Conventional sleep analysis according to Rechtschaffen and Kales (1968) has provided meaningful contributions to the understanding of disturbed sleep architecture in depression. However, there is no characteristic alteration of the sleep cycle, which could serve as a highly specific feature for depressive illness. Therefore, we started to investigate nonlinear properties of sleep electroencephalographic (EEG) data in order to elucidate functional alterations other than those obtained from classical sleep analysis. The application of methods from nonlinear dynamical system theory to EEG data has led to the assumption that the EEG can be treated as a deterministic chaotic process. Chaotic sys…

AdultMalemedicine.medical_specialtyChaoticSleep REMPoison controlLyapunov exponentAudiologyElectroencephalographysymbols.namesakemedicineHumansPharmacology (medical)PsychiatryBiological PsychiatryPsychiatric Status Rating ScalesDepressive DisorderSleep Stagesmedicine.diagnostic_testEye movementElectroencephalographyGeneral MedicineMiddle AgedSleep in non-human animalsPsychiatry and Mental healthNonlinear systemsymbolsFemalePsychologyEuropean Archives of Psychiatry and Clinical Neuroscience
researchProduct

The switch from conventional to atypical antipsychotic treatment should not be based exclusively on the presence of cognitive deficits. A pilot study…

2010

Abstract Background Atypical antipsychotics provide better control of the negative and affective symptoms of schizophrenia when compared with conventional neuroleptics; nevertheless, their heightened ability to improve cognitive dysfunction remains a matter of debate. This study aimed to examine the changes in cognition associated with long-term antipsychotic treatment and to evaluate the effect of the type of antipsychotic (conventional versus novel antipsychotic drugs) on cognitive performance over time. Methods In this naturalistic study, we used a comprehensive neuropsychological battery of tests to assess a sample of schizophrenia patients taking either conventional (n = 13) or novel a…

AdultMalemedicine.medical_specialtyCognition disorderslcsh:RC435-571Teràpia cognitivamedicine.drug_classmedicine.medical_treatmentAtypical antipsychoticPilot ProjectsComorbidityCognitive therapyNeuropsychological TestsTrastorns de la cogniciólcsh:PsychiatryResearch articlemedicineHumansVerbal fluency testLongitudinal StudiesAntipsychotic drugsEffects of sleep deprivation on cognitive performancePsychiatryAntipsychoticRetrospective StudiesPsychiatric Status Rating ScalesCognitionExecutive functionsmedicine.diseasePsychiatry and Mental healthTreatment OutcomeSchizophreniaSchizophreniaFemaleSchizophrenic PsychologyAntipsicòticsEsquizofrèniaVerbal memoryCognition DisordersPsychologyAntipsychotic AgentsClinical psychologyBMC Psychiatry
researchProduct

A combined marker of early non-improvement and the occurrence of melancholic features improve the treatment prediction in patients with Major Depress…

2017

Abstract Background Early Improvement of depressive symptoms within two weeks of antidepressant treatment is a highly sensitive but less specific predictor of later treatment outcome. The aim of this study was to identify clinical features at treatment initiation which are associated with early improvement and non-improvement as well as to identify variables predicting non-remission in patients showing an early improvement. Methods 889 patients with a major depressive episode according to DSM-IV who had participated in an antidepressant treatment trial served as study sample. Clinical predictors (demographic variables, psychopathology, comorbid disorders) were analysed in 698 (79%) early im…

AdultMalemedicine.medical_specialtyComorbidityAvoidant personality disorderPatient ReadmissionSeverity of Illness IndexSuicidal Ideation03 medical and health sciences0302 clinical medicineRisk FactorsRating scaleInternal medicinemedicineHumansMajor depressive episodePsychiatryAtypical depressionDepression (differential diagnoses)Depressive Disorder Majorbusiness.industryMiddle Agedmedicine.diseaseAntidepressive Agents030227 psychiatryPsychiatry and Mental healthClinical PsychologyTreatment OutcomeMajor depressive disorderAntidepressantFemalemedicine.symptombusiness030217 neurology & neurosurgeryPsychopathologyJournal of Affective Disorders
researchProduct

Standing time and daily proportion of sedentary time are associated with pain-related disability in a one month accelerometer measurement in adults w…

2021

Abstract Objectives The association between the subjective experience of pain-related disability (PRD) and device-measured physical activity (PA) and sedentary behavior (SB) in overweight and obese adults is not well known. The aim of this study was to investigate the associations of pain markers with accelerometer-measured SB duration and different intensities of PA among physically inactive middle-aged adults with overweight or obesity. Methods This cross-sectional analysis included 72 subjects (27 men) with mean age of 57.9 (SD 6.7) years and mean BMI of 31.6 (SD 4.1) kg/m2. SB and standing time (ST), breaks in sedentary time, light physical activity (LPA) and moderate-to-vigorous physic…

AdultMalemedicine.medical_specialtyCoping (psychology)Visual analogue scalePainOverweightQuality of lifeAccelerometrymedicineBack painHumansObesitySedentary timebusiness.industryMiddle AgedOverweightmedicine.diseaseObesityOswestry Disability IndexCross-Sectional StudiesAnesthesiology and Pain MedicineQuality of LifePhysical therapyNeurology (clinical)Sedentary Behaviormedicine.symptombusinessScandinavian Journal of Pain
researchProduct

The relevance of anxiety, depression, and coping in patients after liver transplantation

2002

The aim of this study is to investigate the effects of anxiety, depression, and coping on quality of life in patients after liver transplantation. Patients were asked to fill out a postal survey. Two hundred thirty-six of 375 patients (63%) who entered the study returned the questionnaires, and 186 of these patients could be included in the assessment. Anxiety and depression were surveyed using the Hospital Anxiety and Depression Scale; health-related quality of life, using the 36-Item Short-Form Health Survey; and coping strategies, using the Freiburg Questionnaire on Coping With Illness. In terms of physical and mental dimensions of health-related quality of life, psychosocial factors are…

AdultMalemedicine.medical_specialtyCoping (psychology)medicine.medical_treatmentAnxiety depressionAnxietyLiver transplantationHospital Anxiety and Depression ScaleAdaptation PsychologicalmedicineHealth Status IndicatorsHumansIn patientPostoperative PeriodPsychiatryTransplantationHepatologyDepressionbusiness.industrySocial environmentMiddle AgedLiver TransplantationQuality of LifeRegression AnalysisAnxietyFemaleSurgerymedicine.symptombusinessPsychosocialLiver Transplantation
researchProduct

Symptomatic remission in schizophrenia patients: relationship with social functioning, quality of life, and neurocognitive performance.

2011

Abstract Purpose To investigate whether symptomatic remission relates to better outcomes in schizophrenia. Methods Seventy-six schizophrenia patients were assessed using measures of cross-sectional symptomatic remission, social functioning, subjective quality of life (QoL), and cognition. Results Most patients (53; 69.7%) were not in remission. Remitted patients presented significantly better social functioning, better self-reported QoL, insight, and lower levels of depressive symptoms. They also showed a non-significant trend for better executive function, processing speed and verbal memory. Conclusions Symptomatic remission may be a good indicator of better clinical status, social functio…

AdultMalemedicine.medical_specialtyCross-sectional studyNeuropsychological TestsStatistics NonparametricQuality of lifeRecurrencemedicineHumansCognitive skillPsychiatryBiological PsychiatryDepression (differential diagnoses)Psychiatric Status Rating ScalesAnalysis of VarianceCognitionMiddle Agedmedicine.diseasePsychiatry and Mental healthCross-Sectional StudiesSchizophreniaQuality of LifeSchizophreniaFemaleSchizophrenic PsychologySelf ReportVerbal memoryPsychologyCognition DisordersNeurocognitiveSocial AdjustmentClinical psychologySchizophrenia research
researchProduct

Prevalence of burnout in Polish anesthesiologists and anesthetist nursing professionals: A comparative non-randomized cross-sectional study.

2015

The purpose of the study was to assess the burnout levels in nurses ( N = 161) versus physicians ( N = 373). The levels of burnout were evaluated by the Polish adaptation of the Spanish Burnout Inventory (Cronbach’s alpha > .70). High burnout level was found in 18.63 percent nurses and 12.06 percent anesthesiologists, and critical level in 3.74 percent nurses and 5.90 percent anesthetists. There were statistically significant differences in Burnout global score, Enthusiasm toward the job, Psychological exhaustion, and Indolence subscales between nurses and physicians. No significant differences were found between sexes in any variable.

AdultMalemedicine.medical_specialtyCross-sectional studyhealth care facilities manpower and serviceseducationBurnout03 medical and health sciences0302 clinical medicineCronbach's alphaNursinghealth services administrationAnesthesiology0502 economics and businessPrevalenceMedicineHumans030212 general & internal medicineBurnout ProfessionalApplied PsychologyNurse AnesthetistsPsychiatric Status Rating Scalesbusiness.industry05 social sciencesNurse anesthetistMiddle AgedhumanitiesAnesthesiologistsCritical levelCross-Sectional StudiesFamily medicinePsychiatric status rating scalesFemalePolandbusinessbusiness.employerpsychological phenomena and processes050203 business & managementJournal of health psychology
researchProduct

Is assessment of depression equivalent for migrants of different cultural backgrounds? Results from the German population-based Gutenberg Health Stud…

2018

BACKGROUND Bearing in mind the multicultural background of a national population, little is known about the measurement invariance across different cultures or ethnicities of frequently used screeners for depression. For this reason, the main objective of the current study is to assess the measurement invariance of the Patient Health Questionnaire (PHQ-9) across groups with different migration backgrounds. METHODS We provided psychometric analyses (descriptive statistics at item and scale level, reliability analysis, exploratory [EFA] and confirmatory factor analyses [CFA]) comparing a native population with first- and second-generation migrants of the German population-based Gutenberg Heal…

AdultMalemedicine.medical_specialtyCulturePopulationEthnic groupEmigrants and ImmigrantsPatient Health Questionnaire03 medical and health sciencesMental distress0302 clinical medicineGermanyEpidemiologymedicineHumansMeasurement invariance030212 general & internal medicineeducationAgedDepressive Disordereducation.field_of_studyDescriptive statisticsDepressionReproducibility of ResultsMiddle Aged030227 psychiatryPatient Health QuestionnairePsychiatry and Mental healthClinical PsychologyScale (social sciences)FemalePsychologyClinical psychologyDepression and Anxiety
researchProduct

What are depressive symptoms in acutely ill patients with schizophrenia spectrum disorder?

2014

AbstractBackground:Aim was to examine depressive symptoms in acutely ill schizophrenia patients on a single symptom basis and to evaluate their relationship with positive, negative and general psychopathological symptoms.Methods:Two hundred and seventy-eight patients suffering from a schizophrenia spectrum disorder were analysed within a naturalistic study by the German Research Network on Schizophrenia. Using the Calgary Depression Scale for Schizophrenia (CDSS) depressive symptoms were examined and the Positive and Negative Syndrome Scale (PANSS) was applied to assess positive, negative and general symptoms. Correlation and factor analyses were calculated to detect the underlying structur…

AdultMalemedicine.medical_specialtyDepression scaleMedizinSeverity of Illness Index03 medical and health sciences0302 clinical medicineGermanyPrevalencemedicineHumans030212 general & internal medicinePsychiatryDepression (differential diagnoses)Depressive symptomsPsychiatric Status Rating ScalesPositive and Negative Syndrome ScaleDepressionGeneral symptomsMiddle Agedmedicine.disease030227 psychiatry3. Good healthHospitalizationAffectPsychiatry and Mental healthResearch DesignSchizophreniaAcute DiseaseGuiltSchizophreniaFemaleSchizophrenic PsychologyFactor Analysis StatisticalPsychologyPsychopathologyClinical psychologySchizophrenia spectrumEuropean Psychiatry
researchProduct

Intravenous immunoglobulin in primary and secondary chronic progressive multiple sclerosis: a randomized placebo controlled multicentre study

2007

In patients with relapsing-remitting multiple sclerosis (MS), IVIG was shown to reduce the relapse rate and progression of disability. In patients with chronic progressive MS, a beneficial effect of IVIG was not documented in placebo controlled studies. This trial investigated the influence of IVIG in primary (PPMS) and secondary (SPMS) chronic progressive MS. Two-hundred and thirty-one patients stratified for PPMS ( n = 34) and SPMS ( n = 197) were randomly assigned to IVIG 0.4 g/kg per month or to placebo for 24 months. Primary endpoints were 1) the time to sustained progression of disease identified as worsening of the expanded disability status scale (EDSS) sustained for 3 months, and …

AdultMalemedicine.medical_specialtyDiseasePlaceboPlacebosCentral nervous system diseaseDisability EvaluationDegenerative diseaseQuality of lifeRecurrencehemic and lymphatic diseasesInternal medicinemedicineHumansImmunologic FactorsProspective StudiesDepression (differential diagnoses)AgedExpanded Disability Status Scalebusiness.industryMultiple sclerosisImmunoglobulins IntravenousMiddle AgedMultiple Sclerosis Chronic Progressivemedicine.diseaseSurgeryTreatment OutcomeNeurologyDisease ProgressionFemaleNeurology (clinical)businessMultiple Sclerosis Journal
researchProduct